Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Activin helps skin growth and healing mainly through stromal cells and affects keratinocytes based on its amount.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Both mouse and rat models are effective for testing alopecia areata treatments.

Cyclosporin is effective for treating skin conditions in small animals, but requires careful dosing and monitoring for side effects.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Using psychological treatments can help manage skin conditions along with regular medical care.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Dermatologists should screen for and manage psychological issues in patients with skin conditions to improve their quality of life.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

Lichen Planopilaris in teens is rare, often misdiagnosed, and responds well to steroids.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

The Polish Skindex-29 is a reliable and valid questionnaire for assessing the quality of life in Polish dermatology patients.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.

Treating both the mind and skin together, especially by managing stress, can greatly improve outcomes for skin disorders linked to psychological issues.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.